AISPW vs NBIX · rev $23.1M vs P/E 45, rev $2.36B
Airship AI Holdings Inc (AISPW) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Airship AI Holdings Inc (AISPW) common stock listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported AISPW revenue for 2024-12-31 was $23.1M. Net income was -$57.5M. Revenue was up 87.4% from 2023-12-31 to 2024-12-31. AISPW currently screens at market cap $0.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
AISPW currently screens at market cap $0. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the AISPW and NBIX stock pages for the full models.
Not investment advice.